Connell, C. M., Shibata, A., Tookman, L. A., Archibald, K. M., Flak, M. B., Pirlo, K. J., . . . McNeish, I. A. (2011). Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells. American Society for Clinical Investigation.

Connell, Claire M., Atsushi Shibata, Laura A. Tookman, Kyra M. Archibald, Magdalena B. Flak, Katrina J. Pirlo, Michelle Lockley, Sally P. Wheatley, e Iain A. McNeish. Genomic DNA Damage and ATR-Chk1 Signaling Determine Oncolytic Adenoviral Efficacy in Human Ovarian Cancer Cells. American Society for Clinical Investigation, 2011.

Connell, Claire M., et al. Genomic DNA Damage and ATR-Chk1 Signaling Determine Oncolytic Adenoviral Efficacy in Human Ovarian Cancer Cells. American Society for Clinical Investigation, 2011.